制药业创新-领先公司及策略分析(1)

::::StevenSeget20:2070:1973;4Genentech;1983;1991—199513.4%1996—200018.2%1985Genentech——Protropin;AmgenEpogen1989;1991Neupogen2112000763691/3200:1978Genentech200021036.294Genentech17.27720%SKBJanLeschley:“”——:“2/32”1993SmithklineBeecham200020012500:221997502000200200080601325%75%30%3000—10000“”2000PharmaciaGSKAventisAG1033:2——Immunex16050001;103;70%20%20442001305200018.7%19903197011.4%200118.5%Accenture25070008013004000;901001401002008:200865%41/3Tufts“”2001FDA328.0210250%1980198011.9%200118.5%199155103::●●●:“”66——“”7710EdwinMansfield65%118%198312——;;;8840;3-620002001Immunex;102IncyteGenomics2IncyteGenomics2000-2001102000-2001374;2382302000-200157.949940515AstraZeneca20005076200150131110200050112125082%;1001271%200116%20011010:2000-200167IT23-7200121.5%15%14%10%10%8%1111:“”:“80%30-40”:Immunex::Immunex2000-2001EnbrelLeukine1Immunex;Immunex2000112000100ImmunexEnbrel200020012Immunex200011Immunex41%1212Immunex7.71200016.0520006FDAEnbrelImmunexEnbrelEnbrel2004/2005Enbrel3——Immunex,EnbrelLeukineImmunex:::2000-2001122000-200123200822001—200620011997—200013133——/:Genentech::Genentech2000-001RituxanHerceptin13GenentechGenentech,Genentech2200162Genentech3500300Genentech4001414XomaMillenniumActelion3——GenentechGenentechthrombopoetin,Genentech1999-2000Genentech1030:::112002125Takepron1999Actos(pioglitazone)CV261953——1515NE-58095(risedronate)20003CeleraCelera:::122322001721995-2000,Vasotec()2000Prinivil2001Zocor()20052001-20063——:1616;:::50:;1341/32000422516%3——:;;1717:::1(GSK)3GSK2000402000100GSK13650GSK2GSK20022004GSK3——;;;:::20002001:;;;122181820003823ZelmacStarlix3——4020001007:1HTS5200015000025;1919;1000010015012254%R&D;86%;58%20%32020CEOJanLeschley5Consulting2/3300010000500BMSNicholasDracopoli:1“”:10:12121IT200160I3C230%374012Herriling3199870.3%200065.6%:122222:;;“”Lee::3“”62323